Document is current

Article History

Received: 4 February 2025

Accepted: 26 May 2025

First Online: 1 July 2025

Declarations

:

: This was a retrospective study using data from a claims database. Because of the anonymous nature of the analysis and the absence of direct patient involvement, ethical approval and informed patient consent were not required, based on the Ethical Guidelines for Epidemiological Research issued by the Japanese Ministry of Health, Labour and Welfare.

: Not applicable.

: KS has received lecture fees from Biofermin Pharmaceutical Co. Ltd., Fujifilm Medical Co. Ltd., and Takeda Pharmaceutical Company Limited, and consultant fees for participation on a data safety monitoring board or advisory board from Fujifilm Medical Co. Ltd. CS is an employee of Takeda Pharmaceutical Company Limited. MO and RI were employees of Takeda Pharmaceutical Company Limited at the time the study was conducted. No other disclosures were reported.